Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Int Forum Allergy Rhinol ; 8(9): 1001-1012, 2018 09.
Article in English | MEDLINE | ID: mdl-29901280

ABSTRACT

BACKGROUND: Nasal polyposis is characterized by persistent inflammation and remodeling in sinonasal mucosa. Toll-like receptor 9 (TLR9) is a DNA receptor of the innate immune system that plays a pivotal role in fibrosis and inflammatory responses. The aim of this study is to explore the expression, activity, and potential pathogenic role of TLR9 signaling in tissue remodeling in nasal polyp-derived fibroblasts (NPDFs). METHODS: Fibrotic and inflammatory responses elicited by type A CpG oligonucleotides were examined in the NPDFs by a combination of real-time quantitative polymerase chain reaction, Western blot analysis, enzyme-linked immunosorbent assay, and immunofluorescence staining. For these experiments, the NPDFs were stimulated with different TLR9 agonists (CpG A and B) and blocked with inhibitors (MyD88 inhibitor and chloroquine). RESULTS: TLR9 expression was significantly higher in nasal polyposis (NP) tissues compared to control or chronic rhinosinusitis (CRS) mucosa. In the NPDFs, TLR9 showed intracellular localization and expression of TLR9 was increased after treatment with CpG A. CpG A increased production of α-smooth muscle actin (α-SMA), fibronectin, and matrix metalloproteinases (MMPs) (MMP1, MMP2, and MMP9) in the NPDFs, while MyD88 inhibitor and chloroquine, which are known to block the TLR9 signaling pathway, inhibited their production. CpG A also produced type I interferons (IFN-α and IFN-ß), which were inhibited by MyD88 inhibitor. CONCLUSION: Our data indicates that CpG A-induced fibroblast activation and cytokine production were mediated via TLR9 stimulation in NPDFs. Disrupting this process with an inhibitor targeting TLR9 or its downstream signaling pathways could represent a novel approach to CRS with NP (CRSwNP) therapy.


Subject(s)
Fibroblasts/pathology , Nasal Polyps/physiopathology , Signal Transduction/physiology , Sinusitis/physiopathology , Toll-Like Receptor 9/metabolism , Adult , Cells, Cultured , Chloroquine/pharmacology , Cytoplasm/metabolism , Female , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Male , Middle Aged , Nasal Polyps/metabolism , Nasal Polyps/pathology , Oligonucleotides/pharmacology , RNA, Messenger/metabolism , Signal Transduction/drug effects , Sinusitis/metabolism , Sinusitis/pathology , Toll-Like Receptor 9/agonists , Toll-Like Receptor 9/antagonists & inhibitors , Toll-Like Receptor 9/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...